Related Experiment Video
Updated: Jan 27, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
CARLo-7-A plausible biomarker for bladder cancer
Hina Amir1, Mohammad Azam Khan1, Saima Feroz1
1Department of Biosciences, COMSATS Institute of Information Technology, Islamabad, Pakistan.
Abstract:
Cancer is defined as undifferentiated and unchecked growth of cells damaging the surrounding tissue. Cancers manifest altered gene expression. Gene expression is regulated by a diverse array of non-protein-coding RNA. Aberrant expression of long non-coding RNAs (lncRNAs) has been recently found to have functional consequences in cancers. In the current study, we report CARLo-7 as the only bladder cancer-specific lncRNA from the CARLos cluster. The expression of this lncRNA correlates with bladder cancer grade. We propose that CARLo-7 has an oncogenic potential and might be regulator of cell proliferation. Furthermore, by comparison the expression of proto-oncogene MYC, which is the only well-annotated gene close to the cancer - associated linkage disequilibrium blocks of this region, does not show a pronounced change in expression between the low- and high-grade tumours. Our results indicate that CARlo-7 can act as a prognostic marker for bladder cancer.
Insights
CARLo-7 is a novel long non-coding RNA (lncRNA) specific to bladder cancer. Its expression correlates with tumor grade, suggesting CARLo-7 may serve as a prognostic marker for bladder cancer.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer is characterized by uncontrolled cell growth and altered gene expression.
- Non-coding RNAs, particularly long non-coding RNAs (lncRNAs), play crucial roles in regulating gene expression and have been implicated in cancer development.
- Aberrant expression of lncRNAs is increasingly recognized for its functional significance in various cancers.
Purpose of the Study:
- To identify and characterize novel cancer-specific long non-coding RNAs (lncRNAs).
- To investigate the role of CARLo-7, a newly identified lncRNA, in bladder cancer.
- To evaluate CARLo-7 as a potential prognostic marker for bladder cancer.
Main Methods:
- Identification of bladder cancer-specific lncRNAs within the CARLos cluster.
- Correlation analysis of CARLo-7 expression with bladder cancer grade.
- Comparative analysis of CARLo-7 and MYC proto-oncogene expression in low- and high-grade tumors.
Main Results:
- CARLo-7 was identified as the sole bladder cancer-specific lncRNA from the CARLos cluster.
- CARLo-7 expression levels positively correlate with bladder cancer grade.
- Unlike MYC, CARLo-7 shows a pronounced change in expression between low- and high-grade tumors, suggesting a specific role in bladder cancer progression.
Conclusions:
- CARLo-7 is a bladder cancer-specific lncRNA with oncogenic potential.
- CARLo-7 may function as a regulator of cell proliferation in bladder cancer.
- CARLo-7 expression serves as a reliable prognostic marker for bladder cancer, outperforming MYC in this regard.
Related Concept Videos
Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
Anatomy of the Genitourinary System II: Bladder and Urethra
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...

